{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T19:28:47Z","timestamp":1768073327592,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05717-y","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T08:02:33Z","timestamp":1725868953000},"page":"2645-2652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-synthetase and myelodysplastic syndromes with deep morphea: an example of shared immunopathogenesis? A case-based review"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4889-546X","authenticated-orcid":false,"given":"Agust\u00edn","family":"Hern\u00e1ndez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9558-893X","authenticated-orcid":false,"given":"Yatzil","family":"Reyna-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9347-8705","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9","family":"Ostos-Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0985-5609","authenticated-orcid":false,"given":"Beatriz","family":"Alcal\u00e1-Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7882-1488","authenticated-orcid":false,"given":"Jiram","family":"Torres-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3312-5953","authenticated-orcid":false,"given":"Silvia","family":"M\u00e9ndez-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3577-3353","authenticated-orcid":false,"given":"Salvador","family":"Escobar-Ceballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8925-8651","authenticated-orcid":false,"given":"Braulio","family":"Mart\u00ednez-Benitez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1807-0045","authenticated-orcid":false,"given":"Diana","family":"G\u00f3mez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"5717_CR1","doi-asserted-by":"publisher","unstructured":"Hum RM, Lilleker JB, Lamb JA, Oldroyd AGS, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Danieli MG, Oakley P, Griger Z, Nguyen Thi Phuong T, Kodishala C, Vazquez-Del Mercado M, Andersson H, De Paepe B, De Bleecker JL, Maurer B, McCann L, Pipitone N, McHugh N, New RP, Ollier WE, Krogh NS, Vencovsky J, Lundberg IE, Chinoy H (2024) MYONET Registry. Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry. Rheumatology (Oxford). ;63(8):2093\u20132100. https:\/\/doi.org\/10.1093\/rheumatology\/kead481. Erratum in: Rheumatology (Oxford). 2024;63(8):2316. doi: 10.1093\/rheumatology\/keae186","DOI":"10.1093\/rheumatology\/kead481"},{"issue":"12","key":"5717_CR2","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1586\/1744666X.2014.970181","volume":"10","author":"S Giannouli","year":"2014","unstructured":"Giannouli S, Voulgarelis M (2014) A comprehensive review of myelodysplastic syndrome patients with autoimmune diseases. Expert Rev Clin Immunol 10(12):1679\u20131688. https:\/\/doi.org\/10.1586\/1744666X.2014.970181","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"5717_CR3","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00011-023-01773-5","volume":"72","author":"A Cristiano","year":"2023","unstructured":"Cristiano A, Belardi R, Hajrullaj H, Fabiani E, Falconi G, Galossi E, Bernardini S, Voso MT, Nuccetelli M (2023) Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes. Inflamm Res 72(8):1695\u20131707. https:\/\/doi.org\/10.1007\/s00011-023-01773-5","journal-title":"Inflamm Res"},{"key":"5717_CR4","doi-asserted-by":"publisher","unstructured":"Pauling JD, Christopher-Stine L (2021) The etiopathogenic significance, clinical relevance and therapeutic implications of vasculopathy in idiopathic inflammatory myopathy. Rheumatology (Oxford). ;60(4):1593\u20131607. https:\/\/doi.org\/10.1093\/rheumatology\/keaa816. Erratum in: Rheumatology (Oxford). 2021;60(8):3960. doi: 10.1093\/rheumatology\/keab431","DOI":"10.1093\/rheumatology\/keaa816"},{"issue":"2","key":"5717_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.55563\/clinexprheumatol\/l9gudh","volume":"42","author":"RJ Torres","year":"2024","unstructured":"Torres RJ, Pinal FI, Selva OA, Campbell B, Mu\u00f1oz BS, Mej\u00eda DN, N\u00fa\u00f1ez AC, Milisenda J, Casal DM, Pak K, Guill\u00e9n DA, Trallero AE, Gil VA, Mammen AL (2024) Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies. Clin Exp Rheumatol 42(2):367\u2013376. https:\/\/doi.org\/10.55563\/clinexprheumatol\/l9gudh","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"5717_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2174\/1573397119666230905151903","volume":"20","author":"SN Lambova","year":"2024","unstructured":"Lambova SN (2024) The value of Nailfold Capillaroscopy in the classification and Differential diagnosis of Raynaud\u2019s Phenomenon in Rheumatology. Curr Rheumatol Rev 20(2):108\u2013114. https:\/\/doi.org\/10.2174\/1573397119666230905151903","journal-title":"Curr Rheumatol Rev"},{"issue":"5","key":"5717_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ejim.2013.01.002","volume":"24","author":"I Marie","year":"2013","unstructured":"Marie I, Josse S, Decaux O, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Hachulla E, Vittecoq O, Menard JF, Jouen F, Dominique S (2013) Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome. Eur J Intern Med 24(5):474\u2013479. https:\/\/doi.org\/10.1016\/j.ejim.2013.01.002","journal-title":"Eur J Intern Med"},{"key":"5717_CR8","doi-asserted-by":"publisher","first-page":"866087","DOI":"10.3389\/fimmu.2022.866087","volume":"13","author":"AS Galindo-Feria","year":"2022","unstructured":"Galindo-Feria AS, Notarnicola A, Lundberg IE, Horuluoglu B (2022) Aminoacyl-tRNA synthetases: on anti-synthetase syndrome and Beyond. Front Immunol 13:866087. https:\/\/doi.org\/10.3389\/fimmu.2022.866087","journal-title":"Front Immunol"},{"issue":"2","key":"5717_CR9","doi-asserted-by":"publisher","first-page":"rkae049","DOI":"10.1093\/rap\/rkae049","volume":"8","author":"S Yamamoto","year":"2024","unstructured":"Yamamoto S, Yoshida A, Okazaki Y, Gono T, Kuwana M (2024) Clinical phenotyping in patients with anti-synthetase antibodies using cluster analysis. Rheumatol Adv Pract 8(2):rkae049. https:\/\/doi.org\/10.1093\/rap\/rkae049","journal-title":"Rheumatol Adv Pract"},{"issue":"7","key":"5717_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/archderm.138.7.885","volume":"138","author":"A Sparsa","year":"2002","unstructured":"Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, Soria P, Loustaud-Ratti V, Bouyssou-Gauthier ML, Boulinguez S, B\u00e9dane C, Jauberteau MO, Vidal E, Bonnetblanc JM (2002) Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients. Arch Dermatol 138(7):885\u2013890. https:\/\/doi.org\/10.1001\/archderm.138.7.885","journal-title":"Arch Dermatol"},{"key":"5717_CR11","doi-asserted-by":"publisher","unstructured":"Rana J, Moy AP, Piris A, Smith GP (2017) Lupus and scleroderma overlap features in a 28-year-old man with anti-PL-12 anti-synthetase syndrome. Dermatol Online J 23(9). https:\/\/doi.org\/10.5070\/d3239036485","DOI":"10.5070\/d3239036485"},{"issue":"5","key":"5717_CR12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jbspin.2013.02.013","volume":"80","author":"M Ebbo","year":"2013","unstructured":"Ebbo M, Chagnaud C, Figarella-Branger D, Legall S, Harle JR, Schleinitz N (2013) Antisynthethase syndrome presenting as peripheral limb fasciitis. Joint Bone Spine 80(5):528\u2013530. https:\/\/doi.org\/10.1016\/j.jbspin.2013.02.013","journal-title":"Joint Bone Spine"},{"key":"5717_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejim.2023.06.012","volume":"115","author":"A Abel","year":"2023","unstructured":"Abel A, Lazaro E, Ralazamahaleo M, Pierrisnard E, Suzon B, Bonnet F, Merci\u00e9 P, Macey J, Agossou M, Viallard JF, Deligny C, Rivi\u00e8re E (2023) Phenotypic profiles among 72 caucasian and afro-caribbean patients with antisynthetase syndrome involving Anti-PL7 or Anti-PL12 autoantibodies. Eur J Intern Med 115:104\u2013113. https:\/\/doi.org\/10.1016\/j.ejim.2023.06.012","journal-title":"Eur J Intern Med"},{"key":"5717_CR14","doi-asserted-by":"publisher","first-page":"1108623","DOI":"10.3389\/fmed.2023.1108623","volume":"10","author":"C Papara","year":"2023","unstructured":"Papara C, De Luca DA, Bieber K, Vorobyev A, Ludwig RJ, Morphea (2023) The 2023 update. Front Med (Lausanne) 10:1108623. https:\/\/doi.org\/10.3389\/fmed.2023.1108623","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"5717_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/CND.0b013e318175c495","volume":"9","author":"NC Voermans","year":"2008","unstructured":"Voermans NC, Pillen S, de Jong EM, Creemers MC, Lammens M, van Alfen N (2008) Morphea profunda presenting as a neuromuscular mimic. J Clin Neuromuscul Dis 9(4):407\u2013414. https:\/\/doi.org\/10.1097\/CND.0b013e318175c495","journal-title":"J Clin Neuromuscul Dis"},{"issue":"10","key":"5717_CR16","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.jid.2023.04.010","volume":"143","author":"HW Chen","year":"2023","unstructured":"Chen HW, Walker AM, Stein AB, Chen SL, Schollaert-Fitch KL, Torok KS, Jacobe HT (2023) Clinical characteristics Associated with Musculoskeletal Extracutaneous manifestations in Pediatric and Adult Morphea: a prospective, Cohort Study. J Invest Dermatol 143(10):1955\u20131963e3. https:\/\/doi.org\/10.1016\/j.jid.2023.04.010","journal-title":"J Invest Dermatol"},{"issue":"1","key":"5717_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, He J (2024) TGF-\u03b2 signaling in health, disease, and therapeutics. Signal Transduct Target Ther 9(1):61. https:\/\/doi.org\/10.1038\/s41392-024-01764-w","journal-title":"Signal Transduct Target Ther"},{"key":"5717_CR18","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3389\/fimmu.2018.00880","volume":"9","author":"M Swinkels","year":"2018","unstructured":"Swinkels M, Rijkers M, Voorberg J, Vidarsson G, Leebeek FWG, Jansen AJG (2018) Emerging concepts in Immune Thrombocytopenia. Front Immunol 9:880. https:\/\/doi.org\/10.3389\/fimmu.2018.00880","journal-title":"Front Immunol"},{"key":"5717_CR19","doi-asserted-by":"publisher","first-page":"1298665","DOI":"10.3389\/fimmu.2023.1298665","volume":"14","author":"K Komura","year":"2024","unstructured":"Komura K, Yanaba K, Bouaziz JD, Yoshizaki A, Hasegawa M, Varga J, Takehara K, Matsushita T (2024) Perspective to precision medicine in scleroderma. Front Immunol 14:1298665. https:\/\/doi.org\/10.3389\/fimmu.2023.1298665","journal-title":"Front Immunol"},{"key":"5717_CR20","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3389\/fimmu.2019.01487","volume":"10","author":"S Khatri","year":"2019","unstructured":"Khatri S, Torok KS, Mirizio E, Liu C, Astakhova K (2019) Autoantibodies in Morphea: an update. Front Immunol 10:1487. https:\/\/doi.org\/10.3389\/fimmu.2019.01487","journal-title":"Front Immunol"},{"issue":"5","key":"5717_CR21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","volume":"145","author":"JJ Leitenberger","year":"2009","unstructured":"Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT (2009) Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermatol 145(5):545\u2013550. https:\/\/doi.org\/10.1001\/archdermatol.2009.79","journal-title":"Arch Dermatol"},{"issue":"3","key":"5717_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/pde.15178","volume":"40","author":"M Kaur","year":"2023","unstructured":"Kaur M, Sadhukhan S, Bhardwaj A, Patra S, Rao M, Alam A (2023) Linear morphea with overlying lichen sclerosus and calcinosis cutis associated with juvenile dermatomyositis. Pediatr Dermatol 40(3):500\u2013502. https:\/\/doi.org\/10.1111\/pde.15178","journal-title":"Pediatr Dermatol"},{"key":"5717_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.17161\/kjm.vol1415224","volume":"14","author":"A Jibbe","year":"2021","unstructured":"Jibbe A, Neill BC, Tolkachjov SN (2021) Concurrent Dermatomyositis, Celiac Disease, and Dermatitis Herpetiformis in a patient with a history of Morphea. Kans J Med 14:203\u2013205. https:\/\/doi.org\/10.17161\/kjm.vol1415224","journal-title":"Kans J Med"},{"issue":"7","key":"5717_CR24","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1016\/S2352-3026(22)00138-7","volume":"9","author":"MJ Hochman","year":"2022","unstructured":"Hochman MJ, DeZern AE (2022) Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin? Lancet Haematol 9(7):e523\u2013e34. https:\/\/doi.org\/10.1016\/S2352-3026(22)00138-7","journal-title":"Lancet Haematol"},{"key":"5717_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.critrevonc.2017.12.013","volume":"122","author":"C Wang","year":"2018","unstructured":"Wang C, Yang Y, Gao S, Chen J, Yu J, Zhang H et al (2018) Immune dysregulation in myelodysplastic syndrome: clinical features, pathogenesis and therapeutic strategies. Crit Rev Oncol Hematol 122:123\u2013132. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.12.013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"5717_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cll.2024.05.001","volume":"44","author":"E Urrechaga","year":"2024","unstructured":"Urrechaga E (2024) Screening of myelodysplastic syndromes using Research parameters of Complete Blood Count: automated detection of Dysplasia. Clin Lab Med 44(3):387\u2013396. https:\/\/doi.org\/10.1016\/j.cll.2024.05.001","journal-title":"Clin Lab Med"},{"issue":"3","key":"5717_CR27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/rheumatology\/kel297","volume":"46","author":"KT McNallan","year":"2007","unstructured":"McNallan KT, Aponte C, el-Azhary R et al (2007) Immunophenotyping of chimeric cells in localized scleroderma. Rheumatology (Oxford) 46(3):398\u2013402. https:\/\/doi.org\/10.1093\/rheumatology\/kel297","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"5717_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cll.2023.08.007","volume":"44","author":"S Sadigh","year":"2024","unstructured":"Sadigh S, Kim AS (2024) Molecular Pathology of Myeloid neoplasms: Molecular Pattern Recognition. Clin Lab Med 44(2):339\u2013353. https:\/\/doi.org\/10.1016\/j.cll.2023.08.007","journal-title":"Clin Lab Med"},{"issue":"10","key":"5717_CR29","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1365-2362.2004.01417.x","volume":"34","author":"M Voulgarelis","year":"2004","unstructured":"Voulgarelis M, Giannouli S, Ritis K, Tzioufas AG (2004) Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Invest 34(10):690\u2013700. https:\/\/doi.org\/10.1111\/j.1365-2362.2004.01417.x","journal-title":"Eur J Clin Invest"},{"issue":"46","key":"5717_CR30","doi-asserted-by":"publisher","first-page":"e31427","DOI":"10.1097\/MD.0000000000031427","volume":"101","author":"Q Liang","year":"2022","unstructured":"Liang Q, Zhao J, Zhang L, Gao Z, Pan H, Fang L, Shi J (2022) Association of systemic inflammatory and autoimmune manifestations with myelodysplastic syndromes: a systematic review and meta-analysis. Med (Baltim) 101(46):e31427. https:\/\/doi.org\/10.1097\/MD.0000000000031427","journal-title":"Med (Baltim)"},{"issue":"1","key":"5717_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hon.2423","volume":"36","author":"C Fozza","year":"2018","unstructured":"Fozza C (2018) The burden of autoimmunity in myelodysplastic syndromes. Hematol Oncol 36(1):15\u201323. https:\/\/doi.org\/10.1002\/hon.2423","journal-title":"Hematol Oncol"},{"key":"5717_CR32","doi-asserted-by":"publisher","first-page":"1339971","DOI":"10.3389\/fimmu.2024.1339971","volume":"15","author":"XC Zhao","year":"2024","unstructured":"Zhao XC, Ju B, Xiu NN, Sun XY, Meng FJ (2024) When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms. Front Immunol 15:1339971. https:\/\/doi.org\/10.3389\/fimmu.2024.1339971","journal-title":"Front Immunol"},{"issue":"1","key":"5717_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(13)70236-9","volume":"13","author":"KG Gwathmey","year":"2014","unstructured":"Gwathmey KG, Burns TM, Collins MP, Dyck PJ (2014) Vasculitic neuropathies. Lancet Neurol 13(1):67\u201382. https:\/\/doi.org\/10.1016\/S1474-4422(13)70236-9","journal-title":"Lancet Neurol"},{"key":"5717_CR34","unstructured":"Witt AM, Dysgaard T (2023) Vasculitic neuropathy. Ugeskr Laeger. ;185(32):V11220671. Danish. PMID: 37615230"},{"issue":"8","key":"5717_CR35","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/art.40503","volume":"70","author":"C Sciorati","year":"2018","unstructured":"Sciorati C, Monno A, Doglio MG, Rigamonti E, Ascherman DP, Manfredi AA, Rovere-Querini P (2018) Exacerbation of Murine Experimental Autoimmune Myositis by Toll-Like receptor 7\/8. Arthritis Rheumatol 70(8):1276\u20131287. https:\/\/doi.org\/10.1002\/art.40503","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"5717_CR36","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.3390\/ijms25095037","volume":"25","author":"YH Chen","year":"2024","unstructured":"Chen YH, Wu KH, Wu HP (2024) Unraveling the complexities of toll-like receptors: from Molecular mechanisms to clinical applications. Int J Mol Sci 25(9):5037. https:\/\/doi.org\/10.3390\/ijms25095037PMID: 38732254; PMCID: PMC11084218","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5717_CR37","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/ijms19030835","volume":"19","author":"FA Sass","year":"2018","unstructured":"Sass FA, Fuchs M, Pumberger M, Geissler S, Duda GN, Perka C et al (2018) Immunology guides skeletal muscle regeneration. Int J Mol Sci 19(3):835. https:\/\/doi.org\/10.3390\/ijms19030835","journal-title":"Int J Mol Sci"},{"key":"5717_CR38","doi-asserted-by":"publisher","unstructured":"Aydemir D (2024) The impact of NETosis on hematological malignancies as a promising therapeutic target. Front Hematol 3. https:\/\/doi.org\/10.3389\/frhem.2024.1377806","DOI":"10.3389\/frhem.2024.1377806"},{"issue":"Pt 9","key":"5717_CR39","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1093\/brain\/awv192","volume":"138","author":"L Mescam-Mancini","year":"2015","unstructured":"Mescam-Mancini L, Allenbach Y, Hervier B, Devilliers H, Mariampillay K, Dubourg O, Maisonobe T, Gherardi R, Mezin P, Preusse C, Stenzel W, Benveniste O (2015) Anti-jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis. Brain 138(Pt 9):2485\u20132492. https:\/\/doi.org\/10.1093\/brain\/awv192","journal-title":"Brain"},{"issue":"8","key":"5717_CR40","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.3390\/ijms25084453","volume":"25","author":"P Patel","year":"2024","unstructured":"Patel P, Marinock JM, Ajmeri A, Brent LH (2024) A review of Antisynthetase Syndrome-Associated interstitial lung disease. Int J Mol Sci 25(8):4453. https:\/\/doi.org\/10.3390\/ijms25084453","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5717_CR41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/cei.12319","volume":"177","author":"S Zhang","year":"2014","unstructured":"Zhang S, Shu X, Tian X, Chen F, Lu X, Wang G (2014) Enhanced formation and impaired degradation of neutrophil extracellular traps in dermatomyositis and polymyositis: a potential contributor to interstitial lung disease complications. Clin Exp Immunol 177(1):134\u2013141. https:\/\/doi.org\/10.1111\/cei.12319","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"5717_CR42","doi-asserted-by":"publisher","first-page":"e0282919","DOI":"10.1371\/journal.pone.0282919","volume":"18","author":"S Lipka","year":"2023","unstructured":"Lipka S, Ostendorf L, Schneider U, Hiepe F, Apel F, Alexander T (2023) Increased levels of immature and activated low density granulocytes and altered degradation of neutrophil extracellular traps in granulomatosis with polyangiitis. PLoS ONE 18(3):e0282919. https:\/\/doi.org\/10.1371\/journal.pone.0282919","journal-title":"PLoS ONE"},{"issue":"7","key":"5717_CR43","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.4049\/jimmunol.1102404","volume":"188","author":"J Leffler","year":"2012","unstructured":"Leffler J, Martin M, Gullstrand B, Tyd\u00e9n H, Lood C, Truedsson L, Bengtsson AA, Blom AM (2012) Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 188(7):3522\u20133531. https:\/\/doi.org\/10.4049\/jimmunol.1102404","journal-title":"J Immunol"},{"issue":"10","key":"5717_CR44","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.3390\/cells10102667","volume":"10","author":"A Angeletti","year":"2021","unstructured":"Angeletti A, Volpi S, Bruschi M, Lugani F, Vaglio A, Prunotto M, Gattorno M, Schena F, Verrina E, Ravelli A, Ghiggeri GM (2021) Neutrophil Extracellular Traps-DNase balance and autoimmunity. Cells 10(10):2667. https:\/\/doi.org\/10.3390\/cells10102667","journal-title":"Cells"},{"issue":"7","key":"5717_CR45","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.7150\/ijms.53728","volume":"18","author":"B Arneth","year":"2021","unstructured":"Arneth B, Arneth R (2021) Neutrophil Extracellular traps (NETs) and Vasculitis. Int J Med Sci 18(7):1532\u20131540. https:\/\/doi.org\/10.7150\/ijms.53728","journal-title":"Int J Med Sci"},{"issue":"2","key":"5717_CR46","doi-asserted-by":"publisher","first-page":"106","DOI":"10.6004\/jnccn.2022.0009","volume":"20","author":"PL Greenberg","year":"2022","unstructured":"Greenberg PL, Stone RM, Al-Kali A, Bennett JM, Borate U, Brunner AM, Chai-Ho W, Curtin P, de Castro CM, Deeg HJ, DeZern AE, Dinner S, Foucar C, Gaensler K, Garcia-Manero G, Griffiths EA, Head D, Jonas BA, Keel S, Madanat Y, Maness LJ, Mangan J, McCurdy S, McMahon C, Patel B, Reddy VV, Sallman DA, Shallis R, Shami PJ, Thota S, Varshavsky-Yanovsky AN, Westervelt P, Hollinger E, Shead DA, Hochstetler C (2022) NCCN guidelines insights: myelodysplastic syndromes, Version 3.2022. J Natl Compr Canc Netw 20(2):106\u2013117. https:\/\/doi.org\/10.6004\/jnccn.2022.0009","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"5717_CR47","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1634\/theoncologist.12-10-1264","volume":"12","author":"SD Ross","year":"2007","unstructured":"Ross SD, Allen IE, Probst CA, Sercus B, Crean SM, Ranganathan G (2007) Efficacy and safety of erythropoiesis-stimulating proteins in myelodysplastic syndrome: a systematic review and meta-analysis. Oncologist 12(10):1264\u20131273. https:\/\/doi.org\/10.1634\/theoncologist.12-10-1264","journal-title":"Oncologist"},{"issue":"11\u201312","key":"5717_CR48","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00508-023-02300-6","volume":"136","author":"P Gasc\u00f3n","year":"2024","unstructured":"Gasc\u00f3n P, Awada A, Karihtala P, Lorenzen S, Minichsdorfer C (2024) Optimal use of granulocyte colony-stimulating factor prophylaxis to improve survival in cancer patients receiving treatment: an expert view. Wien Klin Wochenschr 136(11\u201312):362\u2013368. https:\/\/doi.org\/10.1007\/s00508-023-02300-6","journal-title":"Wien Klin Wochenschr"},{"key":"5717_CR49","doi-asserted-by":"publisher","first-page":"106856","DOI":"10.1016\/j.leukres.2022.106856","volume":"117","author":"C Fozza","year":"2022","unstructured":"Fozza C, Murtas A, Caocci G, La Nasa G (2022) Autoimmune disorders associated with myelodysplastic syndromes: clinical, prognostic and therapeutic implications. Leuk Res 117:106856. https:\/\/doi.org\/10.1016\/j.leukres.2022.106856","journal-title":"Leuk Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05717-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05717-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05717-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:26:43Z","timestamp":1727299603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05717-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["5717"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05717-y","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient\u2019s legal responsible (daughter) for publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}